کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
6074337 | 1203484 | 2016 | 31 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Impact of the HLA-B*58:01 Allele and Renal Impairment on Allopurinol-Induced Cutaneous Adverse Reactions
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
SJSMaculopapular exanthemaMPECADREGFRAUC - AUCBSA - BSAHuman leukocyte antigen - آنتی ژن لوسکسی انسانHLA - آنتیژن گلبول سفید انسانیchronic kidney disease - بیماری مزمن کلیویSCAR - جای زخمten - دهbody surface area - سطح بدنStevens-Johnson syndrome - سندرم استیونز-جانسونsevere cutaneous adverse reaction - شدید عوارض جانبی پوستیconfidence interval - فاصله اطمینانDRESS - لباسarea under the curve - منطقه تحت منحنیestimated glomerular filtration rate - میزان تصفیه گلومرولی برآورد شده استCKD - نارسایی مزمن کلیهodds ratio - نسبت شانس هاToxic epidermal necrolysis - نکرولیز اپیدرمال سمیCutaneous adverse drug reaction - واکنش داروئی موضعیdrug reaction with eosinophilia and systemic symptoms - واکنش دارویی با ائوزینوفیلیا و نشانه های سیستمیک
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
امراض پوستی
پیش نمایش صفحه اول مقاله
![عکس صفحه اول مقاله: Impact of the HLA-B*58:01 Allele and Renal Impairment on Allopurinol-Induced Cutaneous Adverse Reactions Impact of the HLA-B*58:01 Allele and Renal Impairment on Allopurinol-Induced Cutaneous Adverse Reactions](/preview/png/6074337.png)
چکیده انگلیسی
Allopurinol, a common drug for treating hyperuricemia, is associated with cutaneous adverse drug reactions ranging from mild maculopapular exanthema to life-threatening severe cutaneous adverse reactions, including drug reaction with eosinophilia and systemic symptoms, Stevens-Johnson syndrome, and toxic epidermal necrolysis. We have previously reported that HLA-B*58:01 is strongly associated with allopurinol-induced severe cutaneous adverse reactions in Han Chinese, but the associations of the HLA-B*58:01 genotype in an allopurinol-induced hypersensitivity phenotype remain unclear. To investigate the comprehensive associations of HLA-B*58:01, we enrolled 146 patients with allopurinol-induced cutaneous adverse drug reactions (severe cutaneous adverse reactions, n = 106; maculopapular exanthema, n = 40) and 285 allopurinol-tolerant control subjects. Among these allopurinol-induced cutaneous adverse drug reactions, HLA-B*58:01 was strongly associated with severe cutaneous adverse reactions (odds ratio [OR] = 44.0; 95% confidence interval = 21.5-90.3; P = 2.6 à 10-41), and the association was correlated with disease severity (OR = 44.0 for severe cutaneous adverse reactions, OR = 8.5 for maculopapular exanthema). The gene dosage effect of HLA-B*58:01 also influenced the development of allopurinol-induced cutaneous adverse drug reactions (OR = 15.25 for HLA-B*58:01 heterozygotes and OR = 72.45 for homozygotes). Furthermore, coexistence of HLA-B*58:01 and renal impairment increased the risk and predictive accuracy of allopurinol-induced cutaneous adverse drug reactions (heterozygous HLA-B*58:01 and normal renal function: OR = 15.25, specificity = 82%; homozygous HLA-B*58:01 and severe renal impairment: OR = 1269.45, specificity = 100%). This HLA-B*58:01 correlation study suggests that patients with coexisting HLA-B*58:01 and renal impairment (especially estimated glomerular filtration rate < 30ml/minute/1.73 m2) should be cautious and avoid using allopurinol.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Investigative Dermatology - Volume 136, Issue 7, July 2016, Pages 1373-1381
Journal: Journal of Investigative Dermatology - Volume 136, Issue 7, July 2016, Pages 1373-1381
نویسندگان
Chau Yee Ng, Yu-Ting Yeh, Chuang-Wei Wang, Shuen-Iu Hung, Chih-Hsun Yang, Ya-Ching Chang, Wan-Chun Chang, Yu-Jr Lin, Chee-Jen Chang, Shih-Chi Su, Wen-Lang Fan, Der-Yuan Chen, Yeong-Jian Jan Wu, Ya-Chung Tian, Rosaline Chung-Yee Hui, Wen-Hung Chung,